Improving cervical cancer screening and treatment for HIV positive women in Kenya
Official title: Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
Funded at Emory University · NIH-10931596 · Data updated 2026-11-12
This study is working to help women with HIV in Kenya get better access to cervical cancer screenings and treatment, so they can catch any problems early and stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $122,761 |
| NIH project number | 5U54CA284036-02 |
| Project ID | NIH-10931596 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are HIV positive women living in Kenya who are at risk for cervical cancer.
✕Less likely to help
Patients who are not HIV positive or those who do not reside in Kenya may not benefit from this research.
What this research studies
This research aims to enhance the adoption of cervical cancer screening and improve the linkage to treatment for HIV positive women in Kenya. It addresses significant gaps in the current healthcare system that lead to late-stage cancer diagnoses and preventable health issues. By collaborating with various institutions and engaging community stakeholders, the project seeks to implement effective strategies for cancer control and treatment. The approach includes training healthcare providers and utilizing implementation science to ensure sustainable practices.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better treatment outcomes for cervical cancer among HIV positive women in Kenya.
How similar studies have gone: Previous research has shown success in implementing cancer screening programs in similar populations, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Ngumbau, Nancy Mwongeli — Emory University
- Study coordinator: Ngumbau, Nancy Mwongeli
Related research
Other NIH-funded projects on the same topics.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
HOPE-inG: Increasing cervical cancer screening for women with HIV in Ghana
A study tests a home-based HPV self-sampling approach plus a tailored communication plan to help women living with HIV in Ghana get screened more often for cervical cancer.
-
CODA-based cervical cancer screening for LMICs using CRISPR and fluorescence
A low-resource, rapid test called CODA uses CRISPR and light signals to detect cervical cancer markers in women in sub-Saharan Africa to improve screening.
-
CODA-based cervical cancer screening in low-resource settings
A new, quick, low-cost test using CRISPR and fluorescence readouts to help screen for cervical cancer in women in sub-Saharan Africa.
-
CATSystem: a digital tool to boost cervical cancer screening and follow-up in Kenya
A digital tracking system helps doctors and patients in Kenya improve cervical cancer screening, treatment referrals, and follow-up, especially for women living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.